Global Antiandrogen Drugs Supply, Demand and Key Producers, 2026-2032
The global Antiandrogen Drugs market size is expected to reach $ 11676 million by 2032, rising at a market growth of 4.7% CAGR during the forecast period (2026-2032).
Antiandrogen Drugs are pharmacological agents that directly block or inhibit androgen receptor activity and thereby reduce the biological effects of testosterone, dihydrotestosterone and related androgens in androgen-responsive tissues. This study focuses on direct androgen receptor antagonists used primarily in prostate cancer, covering first-generation agents such as bicalutamide, flutamide and nilutamide and next-generation androgen receptor inhibitors such as enzalutamide, apalutamide and darolutamide. The market is predominantly composed of small-molecule oral solid dosage forms, including tablets, film-coated tablets, capsules and soft capsules, with product specifications differentiated by active ingredient, strength, formulation, dosing schedule and approved disease setting. The therapeutic mechanism centers on preventing androgen-driven receptor signaling and, for newer agents, more comprehensive inhibition of androgen receptor activation, nuclear translocation and downstream transcriptional activity. Antiandrogen Drugs are used across castration-sensitive and castration-resistant prostate cancer settings, often together with medical or surgical androgen-deprivation strategies depending on the specific approved indication.
This report is a detailed and comprehensive analysis of the world market for Antiandrogen Drugs, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Antiandrogen Drugs that contribute to its increasing demand across many markets.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Antiandrogen Drugs market
2. What is the demand of the global Antiandrogen Drugs market?
3. What is the year over year growth of the global Antiandrogen Drugs market?
4. What is the total value of the global Antiandrogen Drugs market?
5. Who are the Major Players in the global Antiandrogen Drugs market?
6. What are the growth factors driving the market demand?
Antiandrogen Drugs are pharmacological agents that directly block or inhibit androgen receptor activity and thereby reduce the biological effects of testosterone, dihydrotestosterone and related androgens in androgen-responsive tissues. This study focuses on direct androgen receptor antagonists used primarily in prostate cancer, covering first-generation agents such as bicalutamide, flutamide and nilutamide and next-generation androgen receptor inhibitors such as enzalutamide, apalutamide and darolutamide. The market is predominantly composed of small-molecule oral solid dosage forms, including tablets, film-coated tablets, capsules and soft capsules, with product specifications differentiated by active ingredient, strength, formulation, dosing schedule and approved disease setting. The therapeutic mechanism centers on preventing androgen-driven receptor signaling and, for newer agents, more comprehensive inhibition of androgen receptor activation, nuclear translocation and downstream transcriptional activity. Antiandrogen Drugs are used across castration-sensitive and castration-resistant prostate cancer settings, often together with medical or surgical androgen-deprivation strategies depending on the specific approved indication.
Report Scope
This report studies the global Antiandrogen Drugs demand, key companies, and key regions.This report is a detailed and comprehensive analysis of the world market for Antiandrogen Drugs, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Antiandrogen Drugs that contribute to its increasing demand across many markets.
Highlights and key features of the study
- Global Antiandrogen Drugs total market, 2021-2032, (USD Million)
- Global Antiandrogen Drugs total market by region & country, CAGR, 2021-2032, (USD Million)
- U.S. VS China: Antiandrogen Drugs total market, key domestic companies, and share, (USD Million)
- Global Antiandrogen Drugs revenue by player, revenue and market share 2021-2026, (USD Million)
- Global Antiandrogen Drugs total market by Structure, CAGR, 2021-2032, (USD Million)
- Global Antiandrogen Drugs total market by Application, CAGR, 2021-2032, (USD Million)
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Antiandrogen Drugs market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Structure, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.Global Antiandrogen Drugs Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
Market Segmentation
Global Antiandrogen Drugs Market, Segmentation by Structure:
- Nonsteroidal Antiandrogens
- Steroidal Antiandrogens
Global Antiandrogen Drugs Market, Segmentation by Shape:
- Tablets
- Capsules
- Soft Capsules
Global Antiandrogen Drugs Market, Segmentation by Application:
- Non-Metastatic Castration-Resistant Prostate Cancer
- Metastatic Castration-Resistant Prostate Cancer
- Metastatic Castration-Sensitive Prostate Cancer
- High-Risk Biochemical Recurrent Non-Metastatic Castration-Sensitive Prostate Cancer
Companies Profiled:
- Astellas Pharma Inc.
- Johnson & Johnson Innovative Medicine
- Bayer AG
- ANI Pharmaceuticals, Inc.
- Sun Pharmaceutical Industries Ltd.
- Teva Pharmaceutical Industries Ltd.
- Apotex Inc.
- Intas Pharmaceuticals Ltd.
- Cipla Ltd.
- Zydus Lifesciences Ltd.
- Sandoz Group AG
- Pinnacle Life Science Pvt. Ltd.
- Orion Corporation
- Zhejiang Hisun Pharmaceutical Co., Ltd.
- Shanghai Fudan Forward Pharmaceutical Co., Ltd.
- Shanghai Zhaohui Pharmaceutical Co., Ltd.
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
- Aurisco Pharmaceutical Co., Ltd.
- Qilu Pharmaceutical (Hainan) Co., Ltd.
- Chengdu Easton Biopharmaceuticals Co., Ltd.
- Sichuan Kelun Pharmaceutical Co., Ltd.
- Jiangsu Hansoh Pharmaceutical Group Co., Ltd.
- Yangtze River Pharmaceutical Group Co., Ltd.
- Zhejiang Nuode Pharmaceutical Co., Ltd.
- Jiangxi Kerui Pharmaceutical Co., Ltd.
- Chengdu Better Pharmaceutical Co., Ltd.
- Shenyang Hongqi Pharmaceutical Co., Ltd.
- Yichang Humanwell Pharmaceutical Co., Ltd.
Key Questions Answered
1. How big is the global Antiandrogen Drugs market?2. What is the demand of the global Antiandrogen Drugs market?
3. What is the year over year growth of the global Antiandrogen Drugs market?
4. What is the total value of the global Antiandrogen Drugs market?
5. Who are the Major Players in the global Antiandrogen Drugs market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Antiandrogen Drugs Introduction
1.2 World Antiandrogen Drugs Market Size & Forecast (2021 & 2025 & 2032)
1.3 World Antiandrogen Drugs Total Market by Region (by Headquarter Location)
1.3.1 World Antiandrogen Drugs Market Size by Region (2021-2032), (by Headquarter Location)
1.3.2 United States Based Company Antiandrogen Drugs Revenue (2021-2032)
1.3.3 China Based Company Antiandrogen Drugs Revenue (2021-2032)
1.3.4 Europe Based Company Antiandrogen Drugs Revenue (2021-2032)
1.3.5 Japan Based Company Antiandrogen Drugs Revenue (2021-2032)
1.3.6 South Korea Based Company Antiandrogen Drugs Revenue (2021-2032)
1.3.7 ASEAN Based Company Antiandrogen Drugs Revenue (2021-2032)
1.3.8 India Based Company Antiandrogen Drugs Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Antiandrogen Drugs Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2 DEMAND SUMMARY
2.1 World Antiandrogen Drugs Consumption Value (2021-2032)
2.2 World Antiandrogen Drugs Consumption Value by Region
2.2.1 World Antiandrogen Drugs Consumption Value by Region (2021-2026)
2.2.2 World Antiandrogen Drugs Consumption Value Forecast by Region (2027-2032)
2.3 United States Antiandrogen Drugs Consumption Value (2021-2032)
2.4 China Antiandrogen Drugs Consumption Value (2021-2032)
2.5 Europe Antiandrogen Drugs Consumption Value (2021-2032)
2.6 Japan Antiandrogen Drugs Consumption Value (2021-2032)
2.7 South Korea Antiandrogen Drugs Consumption Value (2021-2032)
2.8 ASEAN Antiandrogen Drugs Consumption Value (2021-2032)
2.9 India Antiandrogen Drugs Consumption Value (2021-2032)
3 WORLD ANTIANDROGEN DRUGS COMPANIES COMPETITIVE ANALYSIS
3.1 World Antiandrogen Drugs Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Antiandrogen Drugs Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Antiandrogen Drugs in 2025
3.2.3 Global Concentration Ratios (CR8) for Antiandrogen Drugs in 2025
3.3 Antiandrogen Drugs Company Evaluation Quadrant
3.4 Antiandrogen Drugs Market: Overall Company Footprint Analysis
3.4.1 Antiandrogen Drugs Market: Region Footprint
3.4.2 Antiandrogen Drugs Market: Company Product Type Footprint
3.4.3 Antiandrogen Drugs Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Antiandrogen Drugs Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Antiandrogen Drugs Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
4.1.2 United States VS China: Antiandrogen Drugs Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: Antiandrogen Drugs Consumption Value Comparison
4.2.1 United States VS China: Antiandrogen Drugs Consumption Value Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Antiandrogen Drugs Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based Antiandrogen Drugs Companies and Market Share, 2021-2026
4.3.1 United States Based Antiandrogen Drugs Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Antiandrogen Drugs Revenue, (2021-2026)
4.4 China Based Companies Antiandrogen Drugs Revenue and Market Share, 2021-2026
4.4.1 China Based Antiandrogen Drugs Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Antiandrogen Drugs Revenue, (2021-2026)
4.5 Rest of World Based Antiandrogen Drugs Companies and Market Share, 2021-2026
4.5.1 Rest of World Based Antiandrogen Drugs Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies Antiandrogen Drugs Revenue (2021-2026)
5 MARKET ANALYSIS BY STRUCTURE
5.1 World Antiandrogen Drugs Market Size Overview by Structure: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Structure
5.2.1 Nonsteroidal Antiandrogens
5.2.2 Steroidal Antiandrogens
5.3 Market Segment by Structure
5.3.1 World Antiandrogen Drugs Market Size by Structure (2021-2026)
5.3.2 World Antiandrogen Drugs Market Size by Structure (2027-2032)
5.3.3 World Antiandrogen Drugs Market Size Market Share by Structure (2027-2032)
6 MARKET ANALYSIS BY SHAPE
6.1 World Antiandrogen Drugs Market Size Overview by Shape: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Shape
6.2.1 Tablets
6.2.2 Capsules
6.2.3 Soft Capsules
6.3 Market Segment by Shape
6.3.1 World Antiandrogen Drugs Market Size by Shape (2021-2026)
6.3.2 World Antiandrogen Drugs Market Size by Shape (2027-2032)
6.3.3 World Antiandrogen Drugs Market Size Market Share by Shape (2027-2032)
7 MARKET ANALYSIS BY APPLICATION
7.1 World Antiandrogen Drugs Market Size Overview by Application: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Application
7.2.1 Non-Metastatic Castration-Resistant Prostate Cancer
7.2.2 Metastatic Castration-Resistant Prostate Cancer
7.2.3 Metastatic Castration-Sensitive Prostate Cancer
7.2.4 High-Risk Biochemical Recurrent Non-Metastatic Castration-Sensitive Prostate Cancer
7.3 Market Segment by Application
7.3.1 World Antiandrogen Drugs Market Size by Application (2021-2026)
7.3.2 World Antiandrogen Drugs Market Size by Application (2027-2032)
7.3.3 World Antiandrogen Drugs Market Size Market Share by Application (2021-2032)
8 COMPANY PROFILES
8.1 Astellas Pharma Inc.
8.1.1 Astellas Pharma Inc. Details
8.1.2 Astellas Pharma Inc. Major Business
8.1.3 Astellas Pharma Inc. Antiandrogen Drugs Product and Services
8.1.4 Astellas Pharma Inc. Antiandrogen Drugs Revenue, Gross Margin and Market Share (2021-2026)
8.1.5 Astellas Pharma Inc. Recent Developments/Updates
8.1.6 Astellas Pharma Inc. Competitive Strengths & Weaknesses
8.2 Johnson & Johnson Innovative Medicine
8.2.1 Johnson & Johnson Innovative Medicine Details
8.2.2 Johnson & Johnson Innovative Medicine Major Business
8.2.3 Johnson & Johnson Innovative Medicine Antiandrogen Drugs Product and Services
8.2.4 Johnson & Johnson Innovative Medicine Antiandrogen Drugs Revenue, Gross Margin and Market Share (2021-2026)
8.2.5 Johnson & Johnson Innovative Medicine Recent Developments/Updates
8.2.6 Johnson & Johnson Innovative Medicine Competitive Strengths & Weaknesses
8.3 Bayer AG
8.3.1 Bayer AG Details
8.3.2 Bayer AG Major Business
8.3.3 Bayer AG Antiandrogen Drugs Product and Services
8.3.4 Bayer AG Antiandrogen Drugs Revenue, Gross Margin and Market Share (2021-2026)
8.3.5 Bayer AG Recent Developments/Updates
8.3.6 Bayer AG Competitive Strengths & Weaknesses
8.4 ANI Pharmaceuticals, Inc.
8.4.1 ANI Pharmaceuticals, Inc. Details
8.4.2 ANI Pharmaceuticals, Inc. Major Business
8.4.3 ANI Pharmaceuticals, Inc. Antiandrogen Drugs Product and Services
8.4.4 ANI Pharmaceuticals, Inc. Antiandrogen Drugs Revenue, Gross Margin and Market Share (2021-2026)
8.4.5 ANI Pharmaceuticals, Inc. Recent Developments/Updates
8.4.6 ANI Pharmaceuticals, Inc. Competitive Strengths & Weaknesses
8.5 Sun Pharmaceutical Industries Ltd.
8.5.1 Sun Pharmaceutical Industries Ltd. Details
8.5.2 Sun Pharmaceutical Industries Ltd. Major Business
8.5.3 Sun Pharmaceutical Industries Ltd. Antiandrogen Drugs Product and Services
8.5.4 Sun Pharmaceutical Industries Ltd. Antiandrogen Drugs Revenue, Gross Margin and Market Share (2021-2026)
8.5.5 Sun Pharmaceutical Industries Ltd. Recent Developments/Updates
8.5.6 Sun Pharmaceutical Industries Ltd. Competitive Strengths & Weaknesses
8.6 Teva Pharmaceutical Industries Ltd.
8.6.1 Teva Pharmaceutical Industries Ltd. Details
8.6.2 Teva Pharmaceutical Industries Ltd. Major Business
8.6.3 Teva Pharmaceutical Industries Ltd. Antiandrogen Drugs Product and Services
8.6.4 Teva Pharmaceutical Industries Ltd. Antiandrogen Drugs Revenue, Gross Margin and Market Share (2021-2026)
8.6.5 Teva Pharmaceutical Industries Ltd. Recent Developments/Updates
8.6.6 Teva Pharmaceutical Industries Ltd. Competitive Strengths & Weaknesses
8.7 Apotex Inc.
8.7.1 Apotex Inc. Details
8.7.2 Apotex Inc. Major Business
8.7.3 Apotex Inc. Antiandrogen Drugs Product and Services
8.7.4 Apotex Inc. Antiandrogen Drugs Revenue, Gross Margin and Market Share (2021-2026)
8.7.5 Apotex Inc. Recent Developments/Updates
8.7.6 Apotex Inc. Competitive Strengths & Weaknesses
8.8 Intas Pharmaceuticals Ltd.
8.8.1 Intas Pharmaceuticals Ltd. Details
8.8.2 Intas Pharmaceuticals Ltd. Major Business
8.8.3 Intas Pharmaceuticals Ltd. Antiandrogen Drugs Product and Services
8.8.4 Intas Pharmaceuticals Ltd. Antiandrogen Drugs Revenue, Gross Margin and Market Share (2021-2026)
8.8.5 Intas Pharmaceuticals Ltd. Recent Developments/Updates
8.8.6 Intas Pharmaceuticals Ltd. Competitive Strengths & Weaknesses
8.9 Cipla Ltd.
8.9.1 Cipla Ltd. Details
8.9.2 Cipla Ltd. Major Business
8.9.3 Cipla Ltd. Antiandrogen Drugs Product and Services
8.9.4 Cipla Ltd. Antiandrogen Drugs Revenue, Gross Margin and Market Share (2021-2026)
8.9.5 Cipla Ltd. Recent Developments/Updates
8.9.6 Cipla Ltd. Competitive Strengths & Weaknesses
8.10 Zydus Lifesciences Ltd.
8.10.1 Zydus Lifesciences Ltd. Details
8.10.2 Zydus Lifesciences Ltd. Major Business
8.10.3 Zydus Lifesciences Ltd. Antiandrogen Drugs Product and Services
8.10.4 Zydus Lifesciences Ltd. Antiandrogen Drugs Revenue, Gross Margin and Market Share (2021-2026)
8.10.5 Zydus Lifesciences Ltd. Recent Developments/Updates
8.10.6 Zydus Lifesciences Ltd. Competitive Strengths & Weaknesses
8.11 Sandoz Group AG
8.11.1 Sandoz Group AG Details
8.11.2 Sandoz Group AG Major Business
8.11.3 Sandoz Group AG Antiandrogen Drugs Product and Services
8.11.4 Sandoz Group AG Antiandrogen Drugs Revenue, Gross Margin and Market Share (2021-2026)
8.11.5 Sandoz Group AG Recent Developments/Updates
8.11.6 Sandoz Group AG Competitive Strengths & Weaknesses
8.12 Pinnacle Life Science Pvt. Ltd.
8.12.1 Pinnacle Life Science Pvt. Ltd. Details
8.12.2 Pinnacle Life Science Pvt. Ltd. Major Business
8.12.3 Pinnacle Life Science Pvt. Ltd. Antiandrogen Drugs Product and Services
8.12.4 Pinnacle Life Science Pvt. Ltd. Antiandrogen Drugs Revenue, Gross Margin and Market Share (2021-2026)
8.12.5 Pinnacle Life Science Pvt. Ltd. Recent Developments/Updates
8.12.6 Pinnacle Life Science Pvt. Ltd. Competitive Strengths & Weaknesses
8.13 Orion Corporation
8.13.1 Orion Corporation Details
8.13.2 Orion Corporation Major Business
8.13.3 Orion Corporation Antiandrogen Drugs Product and Services
8.13.4 Orion Corporation Antiandrogen Drugs Revenue, Gross Margin and Market Share (2021-2026)
8.13.5 Orion Corporation Recent Developments/Updates
8.13.6 Orion Corporation Competitive Strengths & Weaknesses
8.14 Zhejiang Hisun Pharmaceutical Co., Ltd.
8.14.1 Zhejiang Hisun Pharmaceutical Co., Ltd. Details
8.14.2 Zhejiang Hisun Pharmaceutical Co., Ltd. Major Business
8.14.3 Zhejiang Hisun Pharmaceutical Co., Ltd. Antiandrogen Drugs Product and Services
8.14.4 Zhejiang Hisun Pharmaceutical Co., Ltd. Antiandrogen Drugs Revenue, Gross Margin and Market Share (2021-2026)
8.14.5 Zhejiang Hisun Pharmaceutical Co., Ltd. Recent Developments/Updates
8.14.6 Zhejiang Hisun Pharmaceutical Co., Ltd. Competitive Strengths & Weaknesses
8.15 Shanghai Fudan Forward Pharmaceutical Co., Ltd.
8.15.1 Shanghai Fudan Forward Pharmaceutical Co., Ltd. Details
8.15.2 Shanghai Fudan Forward Pharmaceutical Co., Ltd. Major Business
8.15.3 Shanghai Fudan Forward Pharmaceutical Co., Ltd. Antiandrogen Drugs Product and Services
8.15.4 Shanghai Fudan Forward Pharmaceutical Co., Ltd. Antiandrogen Drugs Revenue, Gross Margin and Market Share (2021-2026)
8.15.5 Shanghai Fudan Forward Pharmaceutical Co., Ltd. Recent Developments/Updates
8.15.6 Shanghai Fudan Forward Pharmaceutical Co., Ltd. Competitive Strengths & Weaknesses
8.16 Shanghai Zhaohui Pharmaceutical Co., Ltd.
8.16.1 Shanghai Zhaohui Pharmaceutical Co., Ltd. Details
8.16.2 Shanghai Zhaohui Pharmaceutical Co., Ltd. Major Business
8.16.3 Shanghai Zhaohui Pharmaceutical Co., Ltd. Antiandrogen Drugs Product and Services
8.16.4 Shanghai Zhaohui Pharmaceutical Co., Ltd. Antiandrogen Drugs Revenue, Gross Margin and Market Share (2021-2026)
8.16.5 Shanghai Zhaohui Pharmaceutical Co., Ltd. Recent Developments/Updates
8.16.6 Shanghai Zhaohui Pharmaceutical Co., Ltd. Competitive Strengths & Weaknesses
8.17 Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
8.17.1 Chia Tai Tianqing Pharmaceutical Group Co., Ltd. Details
8.17.2 Chia Tai Tianqing Pharmaceutical Group Co., Ltd. Major Business
8.17.3 Chia Tai Tianqing Pharmaceutical Group Co., Ltd. Antiandrogen Drugs Product and Services
8.17.4 Chia Tai Tianqing Pharmaceutical Group Co., Ltd. Antiandrogen Drugs Revenue, Gross Margin and Market Share (2021-2026)
8.17.5 Chia Tai Tianqing Pharmaceutical Group Co., Ltd. Recent Developments/Updates
8.17.6 Chia Tai Tianqing Pharmaceutical Group Co., Ltd. Competitive Strengths & Weaknesses
8.18 Aurisco Pharmaceutical Co., Ltd.
8.18.1 Aurisco Pharmaceutical Co., Ltd. Details
8.18.2 Aurisco Pharmaceutical Co., Ltd. Major Business
8.18.3 Aurisco Pharmaceutical Co., Ltd. Antiandrogen Drugs Product and Services
8.18.4 Aurisco Pharmaceutical Co., Ltd. Antiandrogen Drugs Revenue, Gross Margin and Market Share (2021-2026)
8.18.5 Aurisco Pharmaceutical Co., Ltd. Recent Developments/Updates
8.18.6 Aurisco Pharmaceutical Co., Ltd. Competitive Strengths & Weaknesses
8.19 Qilu Pharmaceutical (Hainan) Co., Ltd.
8.19.1 Qilu Pharmaceutical (Hainan) Co., Ltd. Details
8.19.2 Qilu Pharmaceutical (Hainan) Co., Ltd. Major Business
8.19.3 Qilu Pharmaceutical (Hainan) Co., Ltd. Antiandrogen Drugs Product and Services
8.19.4 Qilu Pharmaceutical (Hainan) Co., Ltd. Antiandrogen Drugs Revenue, Gross Margin and Market Share (2021-2026)
8.19.5 Qilu Pharmaceutical (Hainan) Co., Ltd. Recent Developments/Updates
8.19.6 Qilu Pharmaceutical (Hainan) Co., Ltd. Competitive Strengths & Weaknesses
8.20 Chengdu Easton Biopharmaceuticals Co., Ltd.
8.20.1 Chengdu Easton Biopharmaceuticals Co., Ltd. Details
8.20.2 Chengdu Easton Biopharmaceuticals Co., Ltd. Major Business
8.20.3 Chengdu Easton Biopharmaceuticals Co., Ltd. Antiandrogen Drugs Product and Services
8.20.4 Chengdu Easton Biopharmaceuticals Co., Ltd. Antiandrogen Drugs Revenue, Gross Margin and Market Share (2021-2026)
8.20.5 Chengdu Easton Biopharmaceuticals Co., Ltd. Recent Developments/Updates
8.20.6 Chengdu Easton Biopharmaceuticals Co., Ltd. Competitive Strengths & Weaknesses
8.21 Sichuan Kelun Pharmaceutical Co., Ltd.
8.21.1 Sichuan Kelun Pharmaceutical Co., Ltd. Details
8.21.2 Sichuan Kelun Pharmaceutical Co., Ltd. Major Business
8.21.3 Sichuan Kelun Pharmaceutical Co., Ltd. Antiandrogen Drugs Product and Services
8.21.4 Sichuan Kelun Pharmaceutical Co., Ltd. Antiandrogen Drugs Revenue, Gross Margin and Market Share (2021-2026)
8.21.5 Sichuan Kelun Pharmaceutical Co., Ltd. Recent Developments/Updates
8.21.6 Sichuan Kelun Pharmaceutical Co., Ltd. Competitive Strengths & Weaknesses
8.22 Jiangsu Hansoh Pharmaceutical Group Co., Ltd.
8.22.1 Jiangsu Hansoh Pharmaceutical Group Co., Ltd. Details
8.22.2 Jiangsu Hansoh Pharmaceutical Group Co., Ltd. Major Business
8.22.3 Jiangsu Hansoh Pharmaceutical Group Co., Ltd. Antiandrogen Drugs Product and Services
8.22.4 Jiangsu Hansoh Pharmaceutical Group Co., Ltd. Antiandrogen Drugs Revenue, Gross Margin and Market Share (2021-2026)
8.22.5 Jiangsu Hansoh Pharmaceutical Group Co., Ltd. Recent Developments/Updates
8.22.6 Jiangsu Hansoh Pharmaceutical Group Co., Ltd. Competitive Strengths & Weaknesses
8.23 Yangtze River Pharmaceutical Group Co., Ltd.
8.23.1 Yangtze River Pharmaceutical Group Co., Ltd. Details
8.23.2 Yangtze River Pharmaceutical Group Co., Ltd. Major Business
8.23.3 Yangtze River Pharmaceutical Group Co., Ltd. Antiandrogen Drugs Product and Services
8.23.4 Yangtze River Pharmaceutical Group Co., Ltd. Antiandrogen Drugs Revenue, Gross Margin and Market Share (2021-2026)
8.23.5 Yangtze River Pharmaceutical Group Co., Ltd. Recent Developments/Updates
8.23.6 Yangtze River Pharmaceutical Group Co., Ltd. Competitive Strengths & Weaknesses
8.24 Zhejiang Nuode Pharmaceutical Co., Ltd.
8.24.1 Zhejiang Nuode Pharmaceutical Co., Ltd. Details
8.24.2 Zhejiang Nuode Pharmaceutical Co., Ltd. Major Business
8.24.3 Zhejiang Nuode Pharmaceutical Co., Ltd. Antiandrogen Drugs Product and Services
8.24.4 Zhejiang Nuode Pharmaceutical Co., Ltd. Antiandrogen Drugs Revenue, Gross Margin and Market Share (2021-2026)
8.24.5 Zhejiang Nuode Pharmaceutical Co., Ltd. Recent Developments/Updates
8.24.6 Zhejiang Nuode Pharmaceutical Co., Ltd. Competitive Strengths & Weaknesses
8.25 Jiangxi Kerui Pharmaceutical Co., Ltd.
8.25.1 Jiangxi Kerui Pharmaceutical Co., Ltd. Details
8.25.2 Jiangxi Kerui Pharmaceutical Co., Ltd. Major Business
8.25.3 Jiangxi Kerui Pharmaceutical Co., Ltd. Antiandrogen Drugs Product and Services
8.25.4 Jiangxi Kerui Pharmaceutical Co., Ltd. Antiandrogen Drugs Revenue, Gross Margin and Market Share (2021-2026)
8.25.5 Jiangxi Kerui Pharmaceutical Co., Ltd. Recent Developments/Updates
8.25.6 Jiangxi Kerui Pharmaceutical Co., Ltd. Competitive Strengths & Weaknesses
8.26 Chengdu Better Pharmaceutical Co., Ltd.
8.26.1 Chengdu Better Pharmaceutical Co., Ltd. Details
8.26.2 Chengdu Better Pharmaceutical Co., Ltd. Major Business
8.26.3 Chengdu Better Pharmaceutical Co., Ltd. Antiandrogen Drugs Product and Services
8.26.4 Chengdu Better Pharmaceutical Co., Ltd. Antiandrogen Drugs Revenue, Gross Margin and Market Share (2021-2026)
8.26.5 Chengdu Better Pharmaceutical Co., Ltd. Recent Developments/Updates
8.26.6 Chengdu Better Pharmaceutical Co., Ltd. Competitive Strengths & Weaknesses
8.27 Shenyang Hongqi Pharmaceutical Co., Ltd.
8.27.1 Shenyang Hongqi Pharmaceutical Co., Ltd. Details
8.27.2 Shenyang Hongqi Pharmaceutical Co., Ltd. Major Business
8.27.3 Shenyang Hongqi Pharmaceutical Co., Ltd. Antiandrogen Drugs Product and Services
8.27.4 Shenyang Hongqi Pharmaceutical Co., Ltd. Antiandrogen Drugs Revenue, Gross Margin and Market Share (2021-2026)
8.27.5 Shenyang Hongqi Pharmaceutical Co., Ltd. Recent Developments/Updates
8.27.6 Shenyang Hongqi Pharmaceutical Co., Ltd. Competitive Strengths & Weaknesses
8.28 Yichang Humanwell Pharmaceutical Co., Ltd.
8.28.1 Yichang Humanwell Pharmaceutical Co., Ltd. Details
8.28.2 Yichang Humanwell Pharmaceutical Co., Ltd. Major Business
8.28.3 Yichang Humanwell Pharmaceutical Co., Ltd. Antiandrogen Drugs Product and Services
8.28.4 Yichang Humanwell Pharmaceutical Co., Ltd. Antiandrogen Drugs Revenue, Gross Margin and Market Share (2021-2026)
8.28.5 Yichang Humanwell Pharmaceutical Co., Ltd. Recent Developments/Updates
8.28.6 Yichang Humanwell Pharmaceutical Co., Ltd. Competitive Strengths & Weaknesses
9 INDUSTRY CHAIN ANALYSIS
9.1 Antiandrogen Drugs Industry Chain
9.2 Antiandrogen Drugs Upstream Analysis
9.3 Antiandrogen Drugs Midstream Analysis
9.4 Antiandrogen Drugs Downstream Analysis
10 RESEARCH FINDINGS AND CONCLUSION
11 APPENDIX
11.1 Methodology
11.2 Research Process and Data Source
11.3 Disclaimer
1.1 Antiandrogen Drugs Introduction
1.2 World Antiandrogen Drugs Market Size & Forecast (2021 & 2025 & 2032)
1.3 World Antiandrogen Drugs Total Market by Region (by Headquarter Location)
1.3.1 World Antiandrogen Drugs Market Size by Region (2021-2032), (by Headquarter Location)
1.3.2 United States Based Company Antiandrogen Drugs Revenue (2021-2032)
1.3.3 China Based Company Antiandrogen Drugs Revenue (2021-2032)
1.3.4 Europe Based Company Antiandrogen Drugs Revenue (2021-2032)
1.3.5 Japan Based Company Antiandrogen Drugs Revenue (2021-2032)
1.3.6 South Korea Based Company Antiandrogen Drugs Revenue (2021-2032)
1.3.7 ASEAN Based Company Antiandrogen Drugs Revenue (2021-2032)
1.3.8 India Based Company Antiandrogen Drugs Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Antiandrogen Drugs Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2 DEMAND SUMMARY
2.1 World Antiandrogen Drugs Consumption Value (2021-2032)
2.2 World Antiandrogen Drugs Consumption Value by Region
2.2.1 World Antiandrogen Drugs Consumption Value by Region (2021-2026)
2.2.2 World Antiandrogen Drugs Consumption Value Forecast by Region (2027-2032)
2.3 United States Antiandrogen Drugs Consumption Value (2021-2032)
2.4 China Antiandrogen Drugs Consumption Value (2021-2032)
2.5 Europe Antiandrogen Drugs Consumption Value (2021-2032)
2.6 Japan Antiandrogen Drugs Consumption Value (2021-2032)
2.7 South Korea Antiandrogen Drugs Consumption Value (2021-2032)
2.8 ASEAN Antiandrogen Drugs Consumption Value (2021-2032)
2.9 India Antiandrogen Drugs Consumption Value (2021-2032)
3 WORLD ANTIANDROGEN DRUGS COMPANIES COMPETITIVE ANALYSIS
3.1 World Antiandrogen Drugs Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Antiandrogen Drugs Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Antiandrogen Drugs in 2025
3.2.3 Global Concentration Ratios (CR8) for Antiandrogen Drugs in 2025
3.3 Antiandrogen Drugs Company Evaluation Quadrant
3.4 Antiandrogen Drugs Market: Overall Company Footprint Analysis
3.4.1 Antiandrogen Drugs Market: Region Footprint
3.4.2 Antiandrogen Drugs Market: Company Product Type Footprint
3.4.3 Antiandrogen Drugs Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Antiandrogen Drugs Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Antiandrogen Drugs Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
4.1.2 United States VS China: Antiandrogen Drugs Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: Antiandrogen Drugs Consumption Value Comparison
4.2.1 United States VS China: Antiandrogen Drugs Consumption Value Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Antiandrogen Drugs Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based Antiandrogen Drugs Companies and Market Share, 2021-2026
4.3.1 United States Based Antiandrogen Drugs Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Antiandrogen Drugs Revenue, (2021-2026)
4.4 China Based Companies Antiandrogen Drugs Revenue and Market Share, 2021-2026
4.4.1 China Based Antiandrogen Drugs Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Antiandrogen Drugs Revenue, (2021-2026)
4.5 Rest of World Based Antiandrogen Drugs Companies and Market Share, 2021-2026
4.5.1 Rest of World Based Antiandrogen Drugs Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies Antiandrogen Drugs Revenue (2021-2026)
5 MARKET ANALYSIS BY STRUCTURE
5.1 World Antiandrogen Drugs Market Size Overview by Structure: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Structure
5.2.1 Nonsteroidal Antiandrogens
5.2.2 Steroidal Antiandrogens
5.3 Market Segment by Structure
5.3.1 World Antiandrogen Drugs Market Size by Structure (2021-2026)
5.3.2 World Antiandrogen Drugs Market Size by Structure (2027-2032)
5.3.3 World Antiandrogen Drugs Market Size Market Share by Structure (2027-2032)
6 MARKET ANALYSIS BY SHAPE
6.1 World Antiandrogen Drugs Market Size Overview by Shape: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Shape
6.2.1 Tablets
6.2.2 Capsules
6.2.3 Soft Capsules
6.3 Market Segment by Shape
6.3.1 World Antiandrogen Drugs Market Size by Shape (2021-2026)
6.3.2 World Antiandrogen Drugs Market Size by Shape (2027-2032)
6.3.3 World Antiandrogen Drugs Market Size Market Share by Shape (2027-2032)
7 MARKET ANALYSIS BY APPLICATION
7.1 World Antiandrogen Drugs Market Size Overview by Application: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Application
7.2.1 Non-Metastatic Castration-Resistant Prostate Cancer
7.2.2 Metastatic Castration-Resistant Prostate Cancer
7.2.3 Metastatic Castration-Sensitive Prostate Cancer
7.2.4 High-Risk Biochemical Recurrent Non-Metastatic Castration-Sensitive Prostate Cancer
7.3 Market Segment by Application
7.3.1 World Antiandrogen Drugs Market Size by Application (2021-2026)
7.3.2 World Antiandrogen Drugs Market Size by Application (2027-2032)
7.3.3 World Antiandrogen Drugs Market Size Market Share by Application (2021-2032)
8 COMPANY PROFILES
8.1 Astellas Pharma Inc.
8.1.1 Astellas Pharma Inc. Details
8.1.2 Astellas Pharma Inc. Major Business
8.1.3 Astellas Pharma Inc. Antiandrogen Drugs Product and Services
8.1.4 Astellas Pharma Inc. Antiandrogen Drugs Revenue, Gross Margin and Market Share (2021-2026)
8.1.5 Astellas Pharma Inc. Recent Developments/Updates
8.1.6 Astellas Pharma Inc. Competitive Strengths & Weaknesses
8.2 Johnson & Johnson Innovative Medicine
8.2.1 Johnson & Johnson Innovative Medicine Details
8.2.2 Johnson & Johnson Innovative Medicine Major Business
8.2.3 Johnson & Johnson Innovative Medicine Antiandrogen Drugs Product and Services
8.2.4 Johnson & Johnson Innovative Medicine Antiandrogen Drugs Revenue, Gross Margin and Market Share (2021-2026)
8.2.5 Johnson & Johnson Innovative Medicine Recent Developments/Updates
8.2.6 Johnson & Johnson Innovative Medicine Competitive Strengths & Weaknesses
8.3 Bayer AG
8.3.1 Bayer AG Details
8.3.2 Bayer AG Major Business
8.3.3 Bayer AG Antiandrogen Drugs Product and Services
8.3.4 Bayer AG Antiandrogen Drugs Revenue, Gross Margin and Market Share (2021-2026)
8.3.5 Bayer AG Recent Developments/Updates
8.3.6 Bayer AG Competitive Strengths & Weaknesses
8.4 ANI Pharmaceuticals, Inc.
8.4.1 ANI Pharmaceuticals, Inc. Details
8.4.2 ANI Pharmaceuticals, Inc. Major Business
8.4.3 ANI Pharmaceuticals, Inc. Antiandrogen Drugs Product and Services
8.4.4 ANI Pharmaceuticals, Inc. Antiandrogen Drugs Revenue, Gross Margin and Market Share (2021-2026)
8.4.5 ANI Pharmaceuticals, Inc. Recent Developments/Updates
8.4.6 ANI Pharmaceuticals, Inc. Competitive Strengths & Weaknesses
8.5 Sun Pharmaceutical Industries Ltd.
8.5.1 Sun Pharmaceutical Industries Ltd. Details
8.5.2 Sun Pharmaceutical Industries Ltd. Major Business
8.5.3 Sun Pharmaceutical Industries Ltd. Antiandrogen Drugs Product and Services
8.5.4 Sun Pharmaceutical Industries Ltd. Antiandrogen Drugs Revenue, Gross Margin and Market Share (2021-2026)
8.5.5 Sun Pharmaceutical Industries Ltd. Recent Developments/Updates
8.5.6 Sun Pharmaceutical Industries Ltd. Competitive Strengths & Weaknesses
8.6 Teva Pharmaceutical Industries Ltd.
8.6.1 Teva Pharmaceutical Industries Ltd. Details
8.6.2 Teva Pharmaceutical Industries Ltd. Major Business
8.6.3 Teva Pharmaceutical Industries Ltd. Antiandrogen Drugs Product and Services
8.6.4 Teva Pharmaceutical Industries Ltd. Antiandrogen Drugs Revenue, Gross Margin and Market Share (2021-2026)
8.6.5 Teva Pharmaceutical Industries Ltd. Recent Developments/Updates
8.6.6 Teva Pharmaceutical Industries Ltd. Competitive Strengths & Weaknesses
8.7 Apotex Inc.
8.7.1 Apotex Inc. Details
8.7.2 Apotex Inc. Major Business
8.7.3 Apotex Inc. Antiandrogen Drugs Product and Services
8.7.4 Apotex Inc. Antiandrogen Drugs Revenue, Gross Margin and Market Share (2021-2026)
8.7.5 Apotex Inc. Recent Developments/Updates
8.7.6 Apotex Inc. Competitive Strengths & Weaknesses
8.8 Intas Pharmaceuticals Ltd.
8.8.1 Intas Pharmaceuticals Ltd. Details
8.8.2 Intas Pharmaceuticals Ltd. Major Business
8.8.3 Intas Pharmaceuticals Ltd. Antiandrogen Drugs Product and Services
8.8.4 Intas Pharmaceuticals Ltd. Antiandrogen Drugs Revenue, Gross Margin and Market Share (2021-2026)
8.8.5 Intas Pharmaceuticals Ltd. Recent Developments/Updates
8.8.6 Intas Pharmaceuticals Ltd. Competitive Strengths & Weaknesses
8.9 Cipla Ltd.
8.9.1 Cipla Ltd. Details
8.9.2 Cipla Ltd. Major Business
8.9.3 Cipla Ltd. Antiandrogen Drugs Product and Services
8.9.4 Cipla Ltd. Antiandrogen Drugs Revenue, Gross Margin and Market Share (2021-2026)
8.9.5 Cipla Ltd. Recent Developments/Updates
8.9.6 Cipla Ltd. Competitive Strengths & Weaknesses
8.10 Zydus Lifesciences Ltd.
8.10.1 Zydus Lifesciences Ltd. Details
8.10.2 Zydus Lifesciences Ltd. Major Business
8.10.3 Zydus Lifesciences Ltd. Antiandrogen Drugs Product and Services
8.10.4 Zydus Lifesciences Ltd. Antiandrogen Drugs Revenue, Gross Margin and Market Share (2021-2026)
8.10.5 Zydus Lifesciences Ltd. Recent Developments/Updates
8.10.6 Zydus Lifesciences Ltd. Competitive Strengths & Weaknesses
8.11 Sandoz Group AG
8.11.1 Sandoz Group AG Details
8.11.2 Sandoz Group AG Major Business
8.11.3 Sandoz Group AG Antiandrogen Drugs Product and Services
8.11.4 Sandoz Group AG Antiandrogen Drugs Revenue, Gross Margin and Market Share (2021-2026)
8.11.5 Sandoz Group AG Recent Developments/Updates
8.11.6 Sandoz Group AG Competitive Strengths & Weaknesses
8.12 Pinnacle Life Science Pvt. Ltd.
8.12.1 Pinnacle Life Science Pvt. Ltd. Details
8.12.2 Pinnacle Life Science Pvt. Ltd. Major Business
8.12.3 Pinnacle Life Science Pvt. Ltd. Antiandrogen Drugs Product and Services
8.12.4 Pinnacle Life Science Pvt. Ltd. Antiandrogen Drugs Revenue, Gross Margin and Market Share (2021-2026)
8.12.5 Pinnacle Life Science Pvt. Ltd. Recent Developments/Updates
8.12.6 Pinnacle Life Science Pvt. Ltd. Competitive Strengths & Weaknesses
8.13 Orion Corporation
8.13.1 Orion Corporation Details
8.13.2 Orion Corporation Major Business
8.13.3 Orion Corporation Antiandrogen Drugs Product and Services
8.13.4 Orion Corporation Antiandrogen Drugs Revenue, Gross Margin and Market Share (2021-2026)
8.13.5 Orion Corporation Recent Developments/Updates
8.13.6 Orion Corporation Competitive Strengths & Weaknesses
8.14 Zhejiang Hisun Pharmaceutical Co., Ltd.
8.14.1 Zhejiang Hisun Pharmaceutical Co., Ltd. Details
8.14.2 Zhejiang Hisun Pharmaceutical Co., Ltd. Major Business
8.14.3 Zhejiang Hisun Pharmaceutical Co., Ltd. Antiandrogen Drugs Product and Services
8.14.4 Zhejiang Hisun Pharmaceutical Co., Ltd. Antiandrogen Drugs Revenue, Gross Margin and Market Share (2021-2026)
8.14.5 Zhejiang Hisun Pharmaceutical Co., Ltd. Recent Developments/Updates
8.14.6 Zhejiang Hisun Pharmaceutical Co., Ltd. Competitive Strengths & Weaknesses
8.15 Shanghai Fudan Forward Pharmaceutical Co., Ltd.
8.15.1 Shanghai Fudan Forward Pharmaceutical Co., Ltd. Details
8.15.2 Shanghai Fudan Forward Pharmaceutical Co., Ltd. Major Business
8.15.3 Shanghai Fudan Forward Pharmaceutical Co., Ltd. Antiandrogen Drugs Product and Services
8.15.4 Shanghai Fudan Forward Pharmaceutical Co., Ltd. Antiandrogen Drugs Revenue, Gross Margin and Market Share (2021-2026)
8.15.5 Shanghai Fudan Forward Pharmaceutical Co., Ltd. Recent Developments/Updates
8.15.6 Shanghai Fudan Forward Pharmaceutical Co., Ltd. Competitive Strengths & Weaknesses
8.16 Shanghai Zhaohui Pharmaceutical Co., Ltd.
8.16.1 Shanghai Zhaohui Pharmaceutical Co., Ltd. Details
8.16.2 Shanghai Zhaohui Pharmaceutical Co., Ltd. Major Business
8.16.3 Shanghai Zhaohui Pharmaceutical Co., Ltd. Antiandrogen Drugs Product and Services
8.16.4 Shanghai Zhaohui Pharmaceutical Co., Ltd. Antiandrogen Drugs Revenue, Gross Margin and Market Share (2021-2026)
8.16.5 Shanghai Zhaohui Pharmaceutical Co., Ltd. Recent Developments/Updates
8.16.6 Shanghai Zhaohui Pharmaceutical Co., Ltd. Competitive Strengths & Weaknesses
8.17 Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
8.17.1 Chia Tai Tianqing Pharmaceutical Group Co., Ltd. Details
8.17.2 Chia Tai Tianqing Pharmaceutical Group Co., Ltd. Major Business
8.17.3 Chia Tai Tianqing Pharmaceutical Group Co., Ltd. Antiandrogen Drugs Product and Services
8.17.4 Chia Tai Tianqing Pharmaceutical Group Co., Ltd. Antiandrogen Drugs Revenue, Gross Margin and Market Share (2021-2026)
8.17.5 Chia Tai Tianqing Pharmaceutical Group Co., Ltd. Recent Developments/Updates
8.17.6 Chia Tai Tianqing Pharmaceutical Group Co., Ltd. Competitive Strengths & Weaknesses
8.18 Aurisco Pharmaceutical Co., Ltd.
8.18.1 Aurisco Pharmaceutical Co., Ltd. Details
8.18.2 Aurisco Pharmaceutical Co., Ltd. Major Business
8.18.3 Aurisco Pharmaceutical Co., Ltd. Antiandrogen Drugs Product and Services
8.18.4 Aurisco Pharmaceutical Co., Ltd. Antiandrogen Drugs Revenue, Gross Margin and Market Share (2021-2026)
8.18.5 Aurisco Pharmaceutical Co., Ltd. Recent Developments/Updates
8.18.6 Aurisco Pharmaceutical Co., Ltd. Competitive Strengths & Weaknesses
8.19 Qilu Pharmaceutical (Hainan) Co., Ltd.
8.19.1 Qilu Pharmaceutical (Hainan) Co., Ltd. Details
8.19.2 Qilu Pharmaceutical (Hainan) Co., Ltd. Major Business
8.19.3 Qilu Pharmaceutical (Hainan) Co., Ltd. Antiandrogen Drugs Product and Services
8.19.4 Qilu Pharmaceutical (Hainan) Co., Ltd. Antiandrogen Drugs Revenue, Gross Margin and Market Share (2021-2026)
8.19.5 Qilu Pharmaceutical (Hainan) Co., Ltd. Recent Developments/Updates
8.19.6 Qilu Pharmaceutical (Hainan) Co., Ltd. Competitive Strengths & Weaknesses
8.20 Chengdu Easton Biopharmaceuticals Co., Ltd.
8.20.1 Chengdu Easton Biopharmaceuticals Co., Ltd. Details
8.20.2 Chengdu Easton Biopharmaceuticals Co., Ltd. Major Business
8.20.3 Chengdu Easton Biopharmaceuticals Co., Ltd. Antiandrogen Drugs Product and Services
8.20.4 Chengdu Easton Biopharmaceuticals Co., Ltd. Antiandrogen Drugs Revenue, Gross Margin and Market Share (2021-2026)
8.20.5 Chengdu Easton Biopharmaceuticals Co., Ltd. Recent Developments/Updates
8.20.6 Chengdu Easton Biopharmaceuticals Co., Ltd. Competitive Strengths & Weaknesses
8.21 Sichuan Kelun Pharmaceutical Co., Ltd.
8.21.1 Sichuan Kelun Pharmaceutical Co., Ltd. Details
8.21.2 Sichuan Kelun Pharmaceutical Co., Ltd. Major Business
8.21.3 Sichuan Kelun Pharmaceutical Co., Ltd. Antiandrogen Drugs Product and Services
8.21.4 Sichuan Kelun Pharmaceutical Co., Ltd. Antiandrogen Drugs Revenue, Gross Margin and Market Share (2021-2026)
8.21.5 Sichuan Kelun Pharmaceutical Co., Ltd. Recent Developments/Updates
8.21.6 Sichuan Kelun Pharmaceutical Co., Ltd. Competitive Strengths & Weaknesses
8.22 Jiangsu Hansoh Pharmaceutical Group Co., Ltd.
8.22.1 Jiangsu Hansoh Pharmaceutical Group Co., Ltd. Details
8.22.2 Jiangsu Hansoh Pharmaceutical Group Co., Ltd. Major Business
8.22.3 Jiangsu Hansoh Pharmaceutical Group Co., Ltd. Antiandrogen Drugs Product and Services
8.22.4 Jiangsu Hansoh Pharmaceutical Group Co., Ltd. Antiandrogen Drugs Revenue, Gross Margin and Market Share (2021-2026)
8.22.5 Jiangsu Hansoh Pharmaceutical Group Co., Ltd. Recent Developments/Updates
8.22.6 Jiangsu Hansoh Pharmaceutical Group Co., Ltd. Competitive Strengths & Weaknesses
8.23 Yangtze River Pharmaceutical Group Co., Ltd.
8.23.1 Yangtze River Pharmaceutical Group Co., Ltd. Details
8.23.2 Yangtze River Pharmaceutical Group Co., Ltd. Major Business
8.23.3 Yangtze River Pharmaceutical Group Co., Ltd. Antiandrogen Drugs Product and Services
8.23.4 Yangtze River Pharmaceutical Group Co., Ltd. Antiandrogen Drugs Revenue, Gross Margin and Market Share (2021-2026)
8.23.5 Yangtze River Pharmaceutical Group Co., Ltd. Recent Developments/Updates
8.23.6 Yangtze River Pharmaceutical Group Co., Ltd. Competitive Strengths & Weaknesses
8.24 Zhejiang Nuode Pharmaceutical Co., Ltd.
8.24.1 Zhejiang Nuode Pharmaceutical Co., Ltd. Details
8.24.2 Zhejiang Nuode Pharmaceutical Co., Ltd. Major Business
8.24.3 Zhejiang Nuode Pharmaceutical Co., Ltd. Antiandrogen Drugs Product and Services
8.24.4 Zhejiang Nuode Pharmaceutical Co., Ltd. Antiandrogen Drugs Revenue, Gross Margin and Market Share (2021-2026)
8.24.5 Zhejiang Nuode Pharmaceutical Co., Ltd. Recent Developments/Updates
8.24.6 Zhejiang Nuode Pharmaceutical Co., Ltd. Competitive Strengths & Weaknesses
8.25 Jiangxi Kerui Pharmaceutical Co., Ltd.
8.25.1 Jiangxi Kerui Pharmaceutical Co., Ltd. Details
8.25.2 Jiangxi Kerui Pharmaceutical Co., Ltd. Major Business
8.25.3 Jiangxi Kerui Pharmaceutical Co., Ltd. Antiandrogen Drugs Product and Services
8.25.4 Jiangxi Kerui Pharmaceutical Co., Ltd. Antiandrogen Drugs Revenue, Gross Margin and Market Share (2021-2026)
8.25.5 Jiangxi Kerui Pharmaceutical Co., Ltd. Recent Developments/Updates
8.25.6 Jiangxi Kerui Pharmaceutical Co., Ltd. Competitive Strengths & Weaknesses
8.26 Chengdu Better Pharmaceutical Co., Ltd.
8.26.1 Chengdu Better Pharmaceutical Co., Ltd. Details
8.26.2 Chengdu Better Pharmaceutical Co., Ltd. Major Business
8.26.3 Chengdu Better Pharmaceutical Co., Ltd. Antiandrogen Drugs Product and Services
8.26.4 Chengdu Better Pharmaceutical Co., Ltd. Antiandrogen Drugs Revenue, Gross Margin and Market Share (2021-2026)
8.26.5 Chengdu Better Pharmaceutical Co., Ltd. Recent Developments/Updates
8.26.6 Chengdu Better Pharmaceutical Co., Ltd. Competitive Strengths & Weaknesses
8.27 Shenyang Hongqi Pharmaceutical Co., Ltd.
8.27.1 Shenyang Hongqi Pharmaceutical Co., Ltd. Details
8.27.2 Shenyang Hongqi Pharmaceutical Co., Ltd. Major Business
8.27.3 Shenyang Hongqi Pharmaceutical Co., Ltd. Antiandrogen Drugs Product and Services
8.27.4 Shenyang Hongqi Pharmaceutical Co., Ltd. Antiandrogen Drugs Revenue, Gross Margin and Market Share (2021-2026)
8.27.5 Shenyang Hongqi Pharmaceutical Co., Ltd. Recent Developments/Updates
8.27.6 Shenyang Hongqi Pharmaceutical Co., Ltd. Competitive Strengths & Weaknesses
8.28 Yichang Humanwell Pharmaceutical Co., Ltd.
8.28.1 Yichang Humanwell Pharmaceutical Co., Ltd. Details
8.28.2 Yichang Humanwell Pharmaceutical Co., Ltd. Major Business
8.28.3 Yichang Humanwell Pharmaceutical Co., Ltd. Antiandrogen Drugs Product and Services
8.28.4 Yichang Humanwell Pharmaceutical Co., Ltd. Antiandrogen Drugs Revenue, Gross Margin and Market Share (2021-2026)
8.28.5 Yichang Humanwell Pharmaceutical Co., Ltd. Recent Developments/Updates
8.28.6 Yichang Humanwell Pharmaceutical Co., Ltd. Competitive Strengths & Weaknesses
9 INDUSTRY CHAIN ANALYSIS
9.1 Antiandrogen Drugs Industry Chain
9.2 Antiandrogen Drugs Upstream Analysis
9.3 Antiandrogen Drugs Midstream Analysis
9.4 Antiandrogen Drugs Downstream Analysis
10 RESEARCH FINDINGS AND CONCLUSION
11 APPENDIX
11.1 Methodology
11.2 Research Process and Data Source
11.3 Disclaimer
LIST OF TABLES
Table 1. World Antiandrogen Drugs Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World Antiandrogen Drugs Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World Antiandrogen Drugs Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World Antiandrogen Drugs Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World Antiandrogen Drugs Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Antiandrogen Drugs Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World Antiandrogen Drugs Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World Antiandrogen Drugs Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World Antiandrogen Drugs Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key Antiandrogen Drugs Players in 2025
Table 12. World Antiandrogen Drugs Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global Antiandrogen Drugs Company Evaluation Quadrant
Table 14. Head Office of Key Antiandrogen Drugs Players
Table 15. Antiandrogen Drugs Market: Company Product Type Footprint
Table 16. Antiandrogen Drugs Market: Company Product Application Footprint
Table 17. Antiandrogen Drugs Mergers & Acquisitions Activity
Table 18. United States VS China Antiandrogen Drugs Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China Antiandrogen Drugs Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based Antiandrogen Drugs Companies, Headquarters (States, Country)
Table 21. United States Based Companies Antiandrogen Drugs Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies Antiandrogen Drugs Revenue Market Share (2021-2026)
Table 23. China Based Antiandrogen Drugs Companies, Headquarters (Province, Country)
Table 24. China Based Companies Antiandrogen Drugs Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies Antiandrogen Drugs Revenue Market Share (2021-2026)
Table 26. Rest of World Based Antiandrogen Drugs Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies Antiandrogen Drugs Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies Antiandrogen Drugs Revenue Market Share (2021-2026)
Table 29. World Antiandrogen Drugs Market Size by Structure, (USD Million), 2021 & 2025 & 2032
Table 30. World Antiandrogen Drugs Market Size Value by Structure (2021-2026) & (USD Million)
Table 31. World Antiandrogen Drugs Market Size by Structure (2027-2032) & (USD Million)
Table 32. World Antiandrogen Drugs Market Size by Shape, (USD Million), 2021 & 2025 & 2032
Table 33. World Antiandrogen Drugs Market Size Value by Shape (2021-2026) & (USD Million)
Table 34. World Antiandrogen Drugs Market Size by Shape (2027-2032) & (USD Million)
Table 35. World Antiandrogen Drugs Market Size by Application, (USD Million), 2021 & 2025 & 2032
Table 36. World Antiandrogen Drugs Market Size by Application (2021-2026) & (USD Million)
Table 37. World Antiandrogen Drugs Market Size by Application (2027-2032) & (USD Million)
Table 38. Astellas Pharma Inc. Basic Information, Manufacturing Base and Competitors
Table 39. Astellas Pharma Inc. Major Business
Table 40. Astellas Pharma Inc. Antiandrogen Drugs Product and Services
Table 41. Astellas Pharma Inc. Antiandrogen Drugs Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 42. Astellas Pharma Inc. Recent Developments/Updates
Table 43. Astellas Pharma Inc. Competitive Strengths & Weaknesses
Table 44. Johnson & Johnson Innovative Medicine Basic Information, Manufacturing Base and Competitors
Table 45. Johnson & Johnson Innovative Medicine Major Business
Table 46. Johnson & Johnson Innovative Medicine Antiandrogen Drugs Product and Services
Table 47. Johnson & Johnson Innovative Medicine Antiandrogen Drugs Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 48. Johnson & Johnson Innovative Medicine Recent Developments/Updates
Table 49. Johnson & Johnson Innovative Medicine Competitive Strengths & Weaknesses
Table 50. Bayer AG Basic Information, Manufacturing Base and Competitors
Table 51. Bayer AG Major Business
Table 52. Bayer AG Antiandrogen Drugs Product and Services
Table 53. Bayer AG Antiandrogen Drugs Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 54. Bayer AG Recent Developments/Updates
Table 55. Bayer AG Competitive Strengths & Weaknesses
Table 56. ANI Pharmaceuticals, Inc. Basic Information, Manufacturing Base and Competitors
Table 57. ANI Pharmaceuticals, Inc. Major Business
Table 58. ANI Pharmaceuticals, Inc. Antiandrogen Drugs Product and Services
Table 59. ANI Pharmaceuticals, Inc. Antiandrogen Drugs Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 60. ANI Pharmaceuticals, Inc. Recent Developments/Updates
Table 61. ANI Pharmaceuticals, Inc. Competitive Strengths & Weaknesses
Table 62. Sun Pharmaceutical Industries Ltd. Basic Information, Manufacturing Base and Competitors
Table 63. Sun Pharmaceutical Industries Ltd. Major Business
Table 64. Sun Pharmaceutical Industries Ltd. Antiandrogen Drugs Product and Services
Table 65. Sun Pharmaceutical Industries Ltd. Antiandrogen Drugs Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 66. Sun Pharmaceutical Industries Ltd. Recent Developments/Updates
Table 67. Sun Pharmaceutical Industries Ltd. Competitive Strengths & Weaknesses
Table 68. Teva Pharmaceutical Industries Ltd. Basic Information, Manufacturing Base and Competitors
Table 69. Teva Pharmaceutical Industries Ltd. Major Business
Table 70. Teva Pharmaceutical Industries Ltd. Antiandrogen Drugs Product and Services
Table 71. Teva Pharmaceutical Industries Ltd. Antiandrogen Drugs Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 72. Teva Pharmaceutical Industries Ltd. Recent Developments/Updates
Table 73. Teva Pharmaceutical Industries Ltd. Competitive Strengths & Weaknesses
Table 74. Apotex Inc. Basic Information, Manufacturing Base and Competitors
Table 75. Apotex Inc. Major Business
Table 76. Apotex Inc. Antiandrogen Drugs Product and Services
Table 77. Apotex Inc. Antiandrogen Drugs Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 78. Apotex Inc. Recent Developments/Updates
Table 79. Apotex Inc. Competitive Strengths & Weaknesses
Table 80. Intas Pharmaceuticals Ltd. Basic Information, Manufacturing Base and Competitors
Table 81. Intas Pharmaceuticals Ltd. Major Business
Table 82. Intas Pharmaceuticals Ltd. Antiandrogen Drugs Product and Services
Table 83. Intas Pharmaceuticals Ltd. Antiandrogen Drugs Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 84. Intas Pharmaceuticals Ltd. Recent Developments/Updates
Table 85. Intas Pharmaceuticals Ltd. Competitive Strengths & Weaknesses
Table 86. Cipla Ltd. Basic Information, Manufacturing Base and Competitors
Table 87. Cipla Ltd. Major Business
Table 88. Cipla Ltd. Antiandrogen Drugs Product and Services
Table 89. Cipla Ltd. Antiandrogen Drugs Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 90. Cipla Ltd. Recent Developments/Updates
Table 91. Cipla Ltd. Competitive Strengths & Weaknesses
Table 92. Zydus Lifesciences Ltd. Basic Information, Manufacturing Base and Competitors
Table 93. Zydus Lifesciences Ltd. Major Business
Table 94. Zydus Lifesciences Ltd. Antiandrogen Drugs Product and Services
Table 95. Zydus Lifesciences Ltd. Antiandrogen Drugs Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 96. Zydus Lifesciences Ltd. Recent Developments/Updates
Table 97. Zydus Lifesciences Ltd. Competitive Strengths & Weaknesses
Table 98. Sandoz Group AG Basic Information, Manufacturing Base and Competitors
Table 99. Sandoz Group AG Major Business
Table 100. Sandoz Group AG Antiandrogen Drugs Product and Services
Table 101. Sandoz Group AG Antiandrogen Drugs Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 102. Sandoz Group AG Recent Developments/Updates
Table 103. Sandoz Group AG Competitive Strengths & Weaknesses
Table 104. Pinnacle Life Science Pvt. Ltd. Basic Information, Manufacturing Base and Competitors
Table 105. Pinnacle Life Science Pvt. Ltd. Major Business
Table 106. Pinnacle Life Science Pvt. Ltd. Antiandrogen Drugs Product and Services
Table 107. Pinnacle Life Science Pvt. Ltd. Antiandrogen Drugs Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 108. Pinnacle Life Science Pvt. Ltd. Recent Developments/Updates
Table 109. Pinnacle Life Science Pvt. Ltd. Competitive Strengths & Weaknesses
Table 110. Orion Corporation Basic Information, Manufacturing Base and Competitors
Table 111. Orion Corporation Major Business
Table 112. Orion Corporation Antiandrogen Drugs Product and Services
Table 113. Orion Corporation Antiandrogen Drugs Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 114. Orion Corporation Recent Developments/Updates
Table 115. Orion Corporation Competitive Strengths & Weaknesses
Table 116. Zhejiang Hisun Pharmaceutical Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 117. Zhejiang Hisun Pharmaceutical Co., Ltd. Major Business
Table 118. Zhejiang Hisun Pharmaceutical Co., Ltd. Antiandrogen Drugs Product and Services
Table 119. Zhejiang Hisun Pharmaceutical Co., Ltd. Antiandrogen Drugs Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 120. Zhejiang Hisun Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 121. Zhejiang Hisun Pharmaceutical Co., Ltd. Competitive Strengths & Weaknesses
Table 122. Shanghai Fudan Forward Pharmaceutical Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 123. Shanghai Fudan Forward Pharmaceutical Co., Ltd. Major Business
Table 124. Shanghai Fudan Forward Pharmaceutical Co., Ltd. Antiandrogen Drugs Product and Services
Table 125. Shanghai Fudan Forward Pharmaceutical Co., Ltd. Antiandrogen Drugs Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 126. Shanghai Fudan Forward Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 127. Shanghai Fudan Forward Pharmaceutical Co., Ltd. Competitive Strengths & Weaknesses
Table 128. Shanghai Zhaohui Pharmaceutical Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 129. Shanghai Zhaohui Pharmaceutical Co., Ltd. Major Business
Table 130. Shanghai Zhaohui Pharmaceutical Co., Ltd. Antiandrogen Drugs Product and Services
Table 131. Shanghai Zhaohui Pharmaceutical Co., Ltd. Antiandrogen Drugs Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 132. Shanghai Zhaohui Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 133. Shanghai Zhaohui Pharmaceutical Co., Ltd. Competitive Strengths & Weaknesses
Table 134. Chia Tai Tianqing Pharmaceutical Group Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 135. Chia Tai Tianqing Pharmaceutical Group Co., Ltd. Major Business
Table 136. Chia Tai Tianqing Pharmaceutical Group Co., Ltd. Antiandrogen Drugs Product and Services
Table 137. Chia Tai Tianqing Pharmaceutical Group Co., Ltd. Antiandrogen Drugs Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 138. Chia Tai Tianqing Pharmaceutical Group Co., Ltd. Recent Developments/Updates
Table 139. Chia Tai Tianqing Pharmaceutical Group Co., Ltd. Competitive Strengths & Weaknesses
Table 140. Aurisco Pharmaceutical Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 141. Aurisco Pharmaceutical Co., Ltd. Major Business
Table 142. Aurisco Pharmaceutical Co., Ltd. Antiandrogen Drugs Product and Services
Table 143. Aurisco Pharmaceutical Co., Ltd. Antiandrogen Drugs Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 144. Aurisco Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 145. Aurisco Pharmaceutical Co., Ltd. Competitive Strengths & Weaknesses
Table 146. Qilu Pharmaceutical (Hainan) Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 147. Qilu Pharmaceutical (Hainan) Co., Ltd. Major Business
Table 148. Qilu Pharmaceutical (Hainan) Co., Ltd. Antiandrogen Drugs Product and Services
Table 149. Qilu Pharmaceutical (Hainan) Co., Ltd. Antiandrogen Drugs Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 150. Qilu Pharmaceutical (Hainan) Co., Ltd. Recent Developments/Updates
Table 151. Qilu Pharmaceutical (Hainan) Co., Ltd. Competitive Strengths & Weaknesses
Table 152. Chengdu Easton Biopharmaceuticals Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 153. Chengdu Easton Biopharmaceuticals Co., Ltd. Major Business
Table 154. Chengdu Easton Biopharmaceuticals Co., Ltd. Antiandrogen Drugs Product and Services
Table 155. Chengdu Easton Biopharmaceuticals Co., Ltd. Antiandrogen Drugs Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 156. Chengdu Easton Biopharmaceuticals Co., Ltd. Recent Developments/Updates
Table 157. Chengdu Easton Biopharmaceuticals Co., Ltd. Competitive Strengths & Weaknesses
Table 158. Sichuan Kelun Pharmaceutical Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 159. Sichuan Kelun Pharmaceutical Co., Ltd. Major Business
Table 160. Sichuan Kelun Pharmaceutical Co., Ltd. Antiandrogen Drugs Product and Services
Table 161. Sichuan Kelun Pharmaceutical Co., Ltd. Antiandrogen Drugs Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 162. Sichuan Kelun Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 163. Sichuan Kelun Pharmaceutical Co., Ltd. Competitive Strengths & Weaknesses
Table 164. Jiangsu Hansoh Pharmaceutical Group Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 165. Jiangsu Hansoh Pharmaceutical Group Co., Ltd. Major Business
Table 166. Jiangsu Hansoh Pharmaceutical Group Co., Ltd. Antiandrogen Drugs Product and Services
Table 167. Jiangsu Hansoh Pharmaceutical Group Co., Ltd. Antiandrogen Drugs Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 168. Jiangsu Hansoh Pharmaceutical Group Co., Ltd. Recent Developments/Updates
Table 169. Jiangsu Hansoh Pharmaceutical Group Co., Ltd. Competitive Strengths & Weaknesses
Table 170. Yangtze River Pharmaceutical Group Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 171. Yangtze River Pharmaceutical Group Co., Ltd. Major Business
Table 172. Yangtze River Pharmaceutical Group Co., Ltd. Antiandrogen Drugs Product and Services
Table 173. Yangtze River Pharmaceutical Group Co., Ltd. Antiandrogen Drugs Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 174. Yangtze River Pharmaceutical Group Co., Ltd. Recent Developments/Updates
Table 175. Yangtze River Pharmaceutical Group Co., Ltd. Competitive Strengths & Weaknesses
Table 176. Zhejiang Nuode Pharmaceutical Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 177. Zhejiang Nuode Pharmaceutical Co., Ltd. Major Business
Table 178. Zhejiang Nuode Pharmaceutical Co., Ltd. Antiandrogen Drugs Product and Services
Table 179. Zhejiang Nuode Pharmaceutical Co., Ltd. Antiandrogen Drugs Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 180. Zhejiang Nuode Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 181. Zhejiang Nuode Pharmaceutical Co., Ltd. Competitive Strengths & Weaknesses
Table 182. Jiangxi Kerui Pharmaceutical Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 183. Jiangxi Kerui Pharmaceutical Co., Ltd. Major Business
Table 184. Jiangxi Kerui Pharmaceutical Co., Ltd. Antiandrogen Drugs Product and Services
Table 185. Jiangxi Kerui Pharmaceutical Co., Ltd. Antiandrogen Drugs Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 186. Jiangxi Kerui Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 187. Jiangxi Kerui Pharmaceutical Co., Ltd. Competitive Strengths & Weaknesses
Table 188. Chengdu Better Pharmaceutical Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 189. Chengdu Better Pharmaceutical Co., Ltd. Major Business
Table 190. Chengdu Better Pharmaceutical Co., Ltd. Antiandrogen Drugs Product and Services
Table 191. Chengdu Better Pharmaceutical Co., Ltd. Antiandrogen Drugs Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 192. Chengdu Better Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 193. Chengdu Better Pharmaceutical Co., Ltd. Competitive Strengths & Weaknesses
Table 194. Shenyang Hongqi Pharmaceutical Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 195. Shenyang Hongqi Pharmaceutical Co., Ltd. Major Business
Table 196. Shenyang Hongqi Pharmaceutical Co., Ltd. Antiandrogen Drugs Product and Services
Table 197. Shenyang Hongqi Pharmaceutical Co., Ltd. Antiandrogen Drugs Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 198. Shenyang Hongqi Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 199. Shenyang Hongqi Pharmaceutical Co., Ltd. Competitive Strengths & Weaknesses
Table 200. Yichang Humanwell Pharmaceutical Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 201. Yichang Humanwell Pharmaceutical Co., Ltd. Major Business
Table 202. Yichang Humanwell Pharmaceutical Co., Ltd. Antiandrogen Drugs Product and Services
Table 203. Yichang Humanwell Pharmaceutical Co., Ltd. Antiandrogen Drugs Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 204. Yichang Humanwell Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 205. Yichang Humanwell Pharmaceutical Co., Ltd. Competitive Strengths & Weaknesses
Table 206. Global Key Players of Antiandrogen Drugs Upstream (Raw Materials)
Table 207. Global Antiandrogen Drugs Typical Customers
Table 1. World Antiandrogen Drugs Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World Antiandrogen Drugs Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World Antiandrogen Drugs Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World Antiandrogen Drugs Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World Antiandrogen Drugs Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Antiandrogen Drugs Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World Antiandrogen Drugs Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World Antiandrogen Drugs Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World Antiandrogen Drugs Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key Antiandrogen Drugs Players in 2025
Table 12. World Antiandrogen Drugs Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global Antiandrogen Drugs Company Evaluation Quadrant
Table 14. Head Office of Key Antiandrogen Drugs Players
Table 15. Antiandrogen Drugs Market: Company Product Type Footprint
Table 16. Antiandrogen Drugs Market: Company Product Application Footprint
Table 17. Antiandrogen Drugs Mergers & Acquisitions Activity
Table 18. United States VS China Antiandrogen Drugs Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China Antiandrogen Drugs Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based Antiandrogen Drugs Companies, Headquarters (States, Country)
Table 21. United States Based Companies Antiandrogen Drugs Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies Antiandrogen Drugs Revenue Market Share (2021-2026)
Table 23. China Based Antiandrogen Drugs Companies, Headquarters (Province, Country)
Table 24. China Based Companies Antiandrogen Drugs Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies Antiandrogen Drugs Revenue Market Share (2021-2026)
Table 26. Rest of World Based Antiandrogen Drugs Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies Antiandrogen Drugs Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies Antiandrogen Drugs Revenue Market Share (2021-2026)
Table 29. World Antiandrogen Drugs Market Size by Structure, (USD Million), 2021 & 2025 & 2032
Table 30. World Antiandrogen Drugs Market Size Value by Structure (2021-2026) & (USD Million)
Table 31. World Antiandrogen Drugs Market Size by Structure (2027-2032) & (USD Million)
Table 32. World Antiandrogen Drugs Market Size by Shape, (USD Million), 2021 & 2025 & 2032
Table 33. World Antiandrogen Drugs Market Size Value by Shape (2021-2026) & (USD Million)
Table 34. World Antiandrogen Drugs Market Size by Shape (2027-2032) & (USD Million)
Table 35. World Antiandrogen Drugs Market Size by Application, (USD Million), 2021 & 2025 & 2032
Table 36. World Antiandrogen Drugs Market Size by Application (2021-2026) & (USD Million)
Table 37. World Antiandrogen Drugs Market Size by Application (2027-2032) & (USD Million)
Table 38. Astellas Pharma Inc. Basic Information, Manufacturing Base and Competitors
Table 39. Astellas Pharma Inc. Major Business
Table 40. Astellas Pharma Inc. Antiandrogen Drugs Product and Services
Table 41. Astellas Pharma Inc. Antiandrogen Drugs Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 42. Astellas Pharma Inc. Recent Developments/Updates
Table 43. Astellas Pharma Inc. Competitive Strengths & Weaknesses
Table 44. Johnson & Johnson Innovative Medicine Basic Information, Manufacturing Base and Competitors
Table 45. Johnson & Johnson Innovative Medicine Major Business
Table 46. Johnson & Johnson Innovative Medicine Antiandrogen Drugs Product and Services
Table 47. Johnson & Johnson Innovative Medicine Antiandrogen Drugs Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 48. Johnson & Johnson Innovative Medicine Recent Developments/Updates
Table 49. Johnson & Johnson Innovative Medicine Competitive Strengths & Weaknesses
Table 50. Bayer AG Basic Information, Manufacturing Base and Competitors
Table 51. Bayer AG Major Business
Table 52. Bayer AG Antiandrogen Drugs Product and Services
Table 53. Bayer AG Antiandrogen Drugs Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 54. Bayer AG Recent Developments/Updates
Table 55. Bayer AG Competitive Strengths & Weaknesses
Table 56. ANI Pharmaceuticals, Inc. Basic Information, Manufacturing Base and Competitors
Table 57. ANI Pharmaceuticals, Inc. Major Business
Table 58. ANI Pharmaceuticals, Inc. Antiandrogen Drugs Product and Services
Table 59. ANI Pharmaceuticals, Inc. Antiandrogen Drugs Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 60. ANI Pharmaceuticals, Inc. Recent Developments/Updates
Table 61. ANI Pharmaceuticals, Inc. Competitive Strengths & Weaknesses
Table 62. Sun Pharmaceutical Industries Ltd. Basic Information, Manufacturing Base and Competitors
Table 63. Sun Pharmaceutical Industries Ltd. Major Business
Table 64. Sun Pharmaceutical Industries Ltd. Antiandrogen Drugs Product and Services
Table 65. Sun Pharmaceutical Industries Ltd. Antiandrogen Drugs Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 66. Sun Pharmaceutical Industries Ltd. Recent Developments/Updates
Table 67. Sun Pharmaceutical Industries Ltd. Competitive Strengths & Weaknesses
Table 68. Teva Pharmaceutical Industries Ltd. Basic Information, Manufacturing Base and Competitors
Table 69. Teva Pharmaceutical Industries Ltd. Major Business
Table 70. Teva Pharmaceutical Industries Ltd. Antiandrogen Drugs Product and Services
Table 71. Teva Pharmaceutical Industries Ltd. Antiandrogen Drugs Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 72. Teva Pharmaceutical Industries Ltd. Recent Developments/Updates
Table 73. Teva Pharmaceutical Industries Ltd. Competitive Strengths & Weaknesses
Table 74. Apotex Inc. Basic Information, Manufacturing Base and Competitors
Table 75. Apotex Inc. Major Business
Table 76. Apotex Inc. Antiandrogen Drugs Product and Services
Table 77. Apotex Inc. Antiandrogen Drugs Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 78. Apotex Inc. Recent Developments/Updates
Table 79. Apotex Inc. Competitive Strengths & Weaknesses
Table 80. Intas Pharmaceuticals Ltd. Basic Information, Manufacturing Base and Competitors
Table 81. Intas Pharmaceuticals Ltd. Major Business
Table 82. Intas Pharmaceuticals Ltd. Antiandrogen Drugs Product and Services
Table 83. Intas Pharmaceuticals Ltd. Antiandrogen Drugs Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 84. Intas Pharmaceuticals Ltd. Recent Developments/Updates
Table 85. Intas Pharmaceuticals Ltd. Competitive Strengths & Weaknesses
Table 86. Cipla Ltd. Basic Information, Manufacturing Base and Competitors
Table 87. Cipla Ltd. Major Business
Table 88. Cipla Ltd. Antiandrogen Drugs Product and Services
Table 89. Cipla Ltd. Antiandrogen Drugs Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 90. Cipla Ltd. Recent Developments/Updates
Table 91. Cipla Ltd. Competitive Strengths & Weaknesses
Table 92. Zydus Lifesciences Ltd. Basic Information, Manufacturing Base and Competitors
Table 93. Zydus Lifesciences Ltd. Major Business
Table 94. Zydus Lifesciences Ltd. Antiandrogen Drugs Product and Services
Table 95. Zydus Lifesciences Ltd. Antiandrogen Drugs Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 96. Zydus Lifesciences Ltd. Recent Developments/Updates
Table 97. Zydus Lifesciences Ltd. Competitive Strengths & Weaknesses
Table 98. Sandoz Group AG Basic Information, Manufacturing Base and Competitors
Table 99. Sandoz Group AG Major Business
Table 100. Sandoz Group AG Antiandrogen Drugs Product and Services
Table 101. Sandoz Group AG Antiandrogen Drugs Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 102. Sandoz Group AG Recent Developments/Updates
Table 103. Sandoz Group AG Competitive Strengths & Weaknesses
Table 104. Pinnacle Life Science Pvt. Ltd. Basic Information, Manufacturing Base and Competitors
Table 105. Pinnacle Life Science Pvt. Ltd. Major Business
Table 106. Pinnacle Life Science Pvt. Ltd. Antiandrogen Drugs Product and Services
Table 107. Pinnacle Life Science Pvt. Ltd. Antiandrogen Drugs Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 108. Pinnacle Life Science Pvt. Ltd. Recent Developments/Updates
Table 109. Pinnacle Life Science Pvt. Ltd. Competitive Strengths & Weaknesses
Table 110. Orion Corporation Basic Information, Manufacturing Base and Competitors
Table 111. Orion Corporation Major Business
Table 112. Orion Corporation Antiandrogen Drugs Product and Services
Table 113. Orion Corporation Antiandrogen Drugs Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 114. Orion Corporation Recent Developments/Updates
Table 115. Orion Corporation Competitive Strengths & Weaknesses
Table 116. Zhejiang Hisun Pharmaceutical Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 117. Zhejiang Hisun Pharmaceutical Co., Ltd. Major Business
Table 118. Zhejiang Hisun Pharmaceutical Co., Ltd. Antiandrogen Drugs Product and Services
Table 119. Zhejiang Hisun Pharmaceutical Co., Ltd. Antiandrogen Drugs Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 120. Zhejiang Hisun Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 121. Zhejiang Hisun Pharmaceutical Co., Ltd. Competitive Strengths & Weaknesses
Table 122. Shanghai Fudan Forward Pharmaceutical Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 123. Shanghai Fudan Forward Pharmaceutical Co., Ltd. Major Business
Table 124. Shanghai Fudan Forward Pharmaceutical Co., Ltd. Antiandrogen Drugs Product and Services
Table 125. Shanghai Fudan Forward Pharmaceutical Co., Ltd. Antiandrogen Drugs Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 126. Shanghai Fudan Forward Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 127. Shanghai Fudan Forward Pharmaceutical Co., Ltd. Competitive Strengths & Weaknesses
Table 128. Shanghai Zhaohui Pharmaceutical Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 129. Shanghai Zhaohui Pharmaceutical Co., Ltd. Major Business
Table 130. Shanghai Zhaohui Pharmaceutical Co., Ltd. Antiandrogen Drugs Product and Services
Table 131. Shanghai Zhaohui Pharmaceutical Co., Ltd. Antiandrogen Drugs Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 132. Shanghai Zhaohui Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 133. Shanghai Zhaohui Pharmaceutical Co., Ltd. Competitive Strengths & Weaknesses
Table 134. Chia Tai Tianqing Pharmaceutical Group Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 135. Chia Tai Tianqing Pharmaceutical Group Co., Ltd. Major Business
Table 136. Chia Tai Tianqing Pharmaceutical Group Co., Ltd. Antiandrogen Drugs Product and Services
Table 137. Chia Tai Tianqing Pharmaceutical Group Co., Ltd. Antiandrogen Drugs Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 138. Chia Tai Tianqing Pharmaceutical Group Co., Ltd. Recent Developments/Updates
Table 139. Chia Tai Tianqing Pharmaceutical Group Co., Ltd. Competitive Strengths & Weaknesses
Table 140. Aurisco Pharmaceutical Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 141. Aurisco Pharmaceutical Co., Ltd. Major Business
Table 142. Aurisco Pharmaceutical Co., Ltd. Antiandrogen Drugs Product and Services
Table 143. Aurisco Pharmaceutical Co., Ltd. Antiandrogen Drugs Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 144. Aurisco Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 145. Aurisco Pharmaceutical Co., Ltd. Competitive Strengths & Weaknesses
Table 146. Qilu Pharmaceutical (Hainan) Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 147. Qilu Pharmaceutical (Hainan) Co., Ltd. Major Business
Table 148. Qilu Pharmaceutical (Hainan) Co., Ltd. Antiandrogen Drugs Product and Services
Table 149. Qilu Pharmaceutical (Hainan) Co., Ltd. Antiandrogen Drugs Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 150. Qilu Pharmaceutical (Hainan) Co., Ltd. Recent Developments/Updates
Table 151. Qilu Pharmaceutical (Hainan) Co., Ltd. Competitive Strengths & Weaknesses
Table 152. Chengdu Easton Biopharmaceuticals Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 153. Chengdu Easton Biopharmaceuticals Co., Ltd. Major Business
Table 154. Chengdu Easton Biopharmaceuticals Co., Ltd. Antiandrogen Drugs Product and Services
Table 155. Chengdu Easton Biopharmaceuticals Co., Ltd. Antiandrogen Drugs Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 156. Chengdu Easton Biopharmaceuticals Co., Ltd. Recent Developments/Updates
Table 157. Chengdu Easton Biopharmaceuticals Co., Ltd. Competitive Strengths & Weaknesses
Table 158. Sichuan Kelun Pharmaceutical Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 159. Sichuan Kelun Pharmaceutical Co., Ltd. Major Business
Table 160. Sichuan Kelun Pharmaceutical Co., Ltd. Antiandrogen Drugs Product and Services
Table 161. Sichuan Kelun Pharmaceutical Co., Ltd. Antiandrogen Drugs Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 162. Sichuan Kelun Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 163. Sichuan Kelun Pharmaceutical Co., Ltd. Competitive Strengths & Weaknesses
Table 164. Jiangsu Hansoh Pharmaceutical Group Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 165. Jiangsu Hansoh Pharmaceutical Group Co., Ltd. Major Business
Table 166. Jiangsu Hansoh Pharmaceutical Group Co., Ltd. Antiandrogen Drugs Product and Services
Table 167. Jiangsu Hansoh Pharmaceutical Group Co., Ltd. Antiandrogen Drugs Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 168. Jiangsu Hansoh Pharmaceutical Group Co., Ltd. Recent Developments/Updates
Table 169. Jiangsu Hansoh Pharmaceutical Group Co., Ltd. Competitive Strengths & Weaknesses
Table 170. Yangtze River Pharmaceutical Group Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 171. Yangtze River Pharmaceutical Group Co., Ltd. Major Business
Table 172. Yangtze River Pharmaceutical Group Co., Ltd. Antiandrogen Drugs Product and Services
Table 173. Yangtze River Pharmaceutical Group Co., Ltd. Antiandrogen Drugs Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 174. Yangtze River Pharmaceutical Group Co., Ltd. Recent Developments/Updates
Table 175. Yangtze River Pharmaceutical Group Co., Ltd. Competitive Strengths & Weaknesses
Table 176. Zhejiang Nuode Pharmaceutical Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 177. Zhejiang Nuode Pharmaceutical Co., Ltd. Major Business
Table 178. Zhejiang Nuode Pharmaceutical Co., Ltd. Antiandrogen Drugs Product and Services
Table 179. Zhejiang Nuode Pharmaceutical Co., Ltd. Antiandrogen Drugs Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 180. Zhejiang Nuode Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 181. Zhejiang Nuode Pharmaceutical Co., Ltd. Competitive Strengths & Weaknesses
Table 182. Jiangxi Kerui Pharmaceutical Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 183. Jiangxi Kerui Pharmaceutical Co., Ltd. Major Business
Table 184. Jiangxi Kerui Pharmaceutical Co., Ltd. Antiandrogen Drugs Product and Services
Table 185. Jiangxi Kerui Pharmaceutical Co., Ltd. Antiandrogen Drugs Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 186. Jiangxi Kerui Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 187. Jiangxi Kerui Pharmaceutical Co., Ltd. Competitive Strengths & Weaknesses
Table 188. Chengdu Better Pharmaceutical Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 189. Chengdu Better Pharmaceutical Co., Ltd. Major Business
Table 190. Chengdu Better Pharmaceutical Co., Ltd. Antiandrogen Drugs Product and Services
Table 191. Chengdu Better Pharmaceutical Co., Ltd. Antiandrogen Drugs Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 192. Chengdu Better Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 193. Chengdu Better Pharmaceutical Co., Ltd. Competitive Strengths & Weaknesses
Table 194. Shenyang Hongqi Pharmaceutical Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 195. Shenyang Hongqi Pharmaceutical Co., Ltd. Major Business
Table 196. Shenyang Hongqi Pharmaceutical Co., Ltd. Antiandrogen Drugs Product and Services
Table 197. Shenyang Hongqi Pharmaceutical Co., Ltd. Antiandrogen Drugs Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 198. Shenyang Hongqi Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 199. Shenyang Hongqi Pharmaceutical Co., Ltd. Competitive Strengths & Weaknesses
Table 200. Yichang Humanwell Pharmaceutical Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 201. Yichang Humanwell Pharmaceutical Co., Ltd. Major Business
Table 202. Yichang Humanwell Pharmaceutical Co., Ltd. Antiandrogen Drugs Product and Services
Table 203. Yichang Humanwell Pharmaceutical Co., Ltd. Antiandrogen Drugs Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 204. Yichang Humanwell Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 205. Yichang Humanwell Pharmaceutical Co., Ltd. Competitive Strengths & Weaknesses
Table 206. Global Key Players of Antiandrogen Drugs Upstream (Raw Materials)
Table 207. Global Antiandrogen Drugs Typical Customers
LIST OF FIGURES
Figure 1. Antiandrogen Drugs Picture
Figure 2. World Antiandrogen Drugs Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Antiandrogen Drugs Total Revenue (2021-2032) & (USD Million)
Figure 4. World Antiandrogen Drugs Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World Antiandrogen Drugs Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company Antiandrogen Drugs Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company Antiandrogen Drugs Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company Antiandrogen Drugs Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company Antiandrogen Drugs Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company Antiandrogen Drugs Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company Antiandrogen Drugs Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company Antiandrogen Drugs Revenue (2021-2032) & (USD Million)
Figure 13. Antiandrogen Drugs Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Antiandrogen Drugs Consumption Value (2021-2032) & (USD Million)
Figure 16. World Antiandrogen Drugs Consumption Value Market Share by Region (2021-2032)
Figure 17. United States Antiandrogen Drugs Consumption Value (2021-2032) & (USD Million)
Figure 18. China Antiandrogen Drugs Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe Antiandrogen Drugs Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan Antiandrogen Drugs Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea Antiandrogen Drugs Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN Antiandrogen Drugs Consumption Value (2021-2032) & (USD Million)
Figure 23. India Antiandrogen Drugs Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of Antiandrogen Drugs by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Antiandrogen Drugs Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Antiandrogen Drugs Markets in 2025
Figure 27. United States VS China: Antiandrogen Drugs Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Antiandrogen Drugs Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World Antiandrogen Drugs Market Size by Structure, (USD Million), 2021 & 2025 & 2032
Figure 30. World Antiandrogen Drugs Market Size Market Share by Structure in 2025
Figure 31. Nonsteroidal Antiandrogens
Figure 32. Steroidal Antiandrogens
Figure 33. World Antiandrogen Drugs Market Size Market Share by Structure (2021-2032)
Figure 34. World Antiandrogen Drugs Market Size by Shape, (USD Million), 2021 & 2025 & 2032
Figure 35. World Antiandrogen Drugs Market Size Market Share by Shape in 2025
Figure 36. Tablets
Figure 37. Capsules
Figure 38. Soft Capsules
Figure 39. World Antiandrogen Drugs Market Size Market Share by Shape (2021-2032)
Figure 40. World Antiandrogen Drugs Market Size by Application, (USD Million), 2021 & 2025 & 2032
Figure 41. World Antiandrogen Drugs Market Size Market Share by Application in 2025
Figure 42. Non-Metastatic Castration-Resistant Prostate Cancer
Figure 43. Metastatic Castration-Resistant Prostate Cancer
Figure 44. Metastatic Castration-Sensitive Prostate Cancer
Figure 45. High-Risk Biochemical Recurrent Non-Metastatic Castration-Sensitive Prostate Cancer
Figure 46. World Antiandrogen Drugs Market Size Market Share by Application (2021-2032)
Figure 47. Antiandrogen Drugs Industrial Chain
Figure 48. Methodology
Figure 49. Research Process and Data Source
Figure 1. Antiandrogen Drugs Picture
Figure 2. World Antiandrogen Drugs Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Antiandrogen Drugs Total Revenue (2021-2032) & (USD Million)
Figure 4. World Antiandrogen Drugs Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World Antiandrogen Drugs Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company Antiandrogen Drugs Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company Antiandrogen Drugs Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company Antiandrogen Drugs Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company Antiandrogen Drugs Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company Antiandrogen Drugs Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company Antiandrogen Drugs Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company Antiandrogen Drugs Revenue (2021-2032) & (USD Million)
Figure 13. Antiandrogen Drugs Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Antiandrogen Drugs Consumption Value (2021-2032) & (USD Million)
Figure 16. World Antiandrogen Drugs Consumption Value Market Share by Region (2021-2032)
Figure 17. United States Antiandrogen Drugs Consumption Value (2021-2032) & (USD Million)
Figure 18. China Antiandrogen Drugs Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe Antiandrogen Drugs Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan Antiandrogen Drugs Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea Antiandrogen Drugs Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN Antiandrogen Drugs Consumption Value (2021-2032) & (USD Million)
Figure 23. India Antiandrogen Drugs Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of Antiandrogen Drugs by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Antiandrogen Drugs Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Antiandrogen Drugs Markets in 2025
Figure 27. United States VS China: Antiandrogen Drugs Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Antiandrogen Drugs Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World Antiandrogen Drugs Market Size by Structure, (USD Million), 2021 & 2025 & 2032
Figure 30. World Antiandrogen Drugs Market Size Market Share by Structure in 2025
Figure 31. Nonsteroidal Antiandrogens
Figure 32. Steroidal Antiandrogens
Figure 33. World Antiandrogen Drugs Market Size Market Share by Structure (2021-2032)
Figure 34. World Antiandrogen Drugs Market Size by Shape, (USD Million), 2021 & 2025 & 2032
Figure 35. World Antiandrogen Drugs Market Size Market Share by Shape in 2025
Figure 36. Tablets
Figure 37. Capsules
Figure 38. Soft Capsules
Figure 39. World Antiandrogen Drugs Market Size Market Share by Shape (2021-2032)
Figure 40. World Antiandrogen Drugs Market Size by Application, (USD Million), 2021 & 2025 & 2032
Figure 41. World Antiandrogen Drugs Market Size Market Share by Application in 2025
Figure 42. Non-Metastatic Castration-Resistant Prostate Cancer
Figure 43. Metastatic Castration-Resistant Prostate Cancer
Figure 44. Metastatic Castration-Sensitive Prostate Cancer
Figure 45. High-Risk Biochemical Recurrent Non-Metastatic Castration-Sensitive Prostate Cancer
Figure 46. World Antiandrogen Drugs Market Size Market Share by Application (2021-2032)
Figure 47. Antiandrogen Drugs Industrial Chain
Figure 48. Methodology
Figure 49. Research Process and Data Source
